CompletedNot Applicable

Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

Austria60 participantsStarted 2008-08

Plain-language summary

Macular Hole Surgery with two different Dyes

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Idiopathic stage 3 and 4 macular holes * Stage 2 macular holes, followed up for at least 6 months * Pseudophakic and phakic eyes * Age over 60 years Exclusion Criteria: * Traumatic macular holes * Secondary macular holes * Severe ocular diseases

What they're measuring

Macular Hole Closure Rate

Timeframe: 12 Months

Trial details

NCT IDNCT00757471

SponsorThe Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-08

View on ClinicalTrials.gov More Idiopathic Macular Holes trials